|
Volumn 24, Issue 12, 2009, Pages 1852-1854
|
Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLONAZEPAM;
GLYCINE RECEPTOR;
GLYCINE RECEPTOR ALPHA 1;
GLYCINE TRANSPORTER 2;
PHENOBARBITAL;
UNCLASSIFIED DRUG;
ANXIETY DISORDER;
BABINSKI REFLEX;
BEHAVIOR DISORDER;
CASE REPORT;
CHILD;
CONTROLLED STUDY;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DISEASE COURSE;
DRUG EFFICACY;
DYSPHAGIA;
ELECTROENCEPHALOGRAPHY;
ELECTROMYOGRAM;
GENETIC ANALYSIS;
HUMAN;
HYPEREKPLEXIA;
LETTER;
MALE;
MISSENSE MUTATION;
MUSCLE RIGIDITY;
PARASOMNIA;
PHENOTYPE;
PRIORITY JOURNAL;
SCHOOL CHILD;
TONIC CLONIC SEIZURE;
VIDEORECORDING;
ANTICONVULSANTS;
CHILD;
CLONAZEPAM;
ELECTROMYOGRAPHY;
GABA PLASMA MEMBRANE TRANSPORT PROTEINS;
HUMANS;
MALE;
MUSCLE HYPERTONIA;
MUSCLE, SKELETAL;
PHARMACOGENETICS;
REFLEX, ABNORMAL;
|
EID: 70449990554
PISSN: 08853185
EISSN: 15318257
Source Type: Journal
DOI: 10.1002/mds.22493 Document Type: Letter |
Times cited : (14)
|
References (7)
|